Status:
COMPLETED
Effectiveness of a Cream for Treatment of Dermatitis in Patients Whith Breast Cancer
Lead Sponsor:
Hospital Universitario Reina Sofia de Cordoba
Conditions:
DERMATITIS INDUCED BY RADIOTHERAPY IN PATIENTS WHITH BREAST CANCER
Eligibility:
All Genders
14+ years
Phase:
NA
Brief Summary
It is intended to evaluate the effect of a marketed cream (Alantel®) based on natural products at high concentrations for the preventive and curative treatment (early stages) of radiation-induced derm...
Eligibility Criteria
Inclusion
- Patients 14 years of age or older
- Diagnosed with cancer and who are or have recently received radiotherapy treatment.
- We will include patients without dermatitis or with acute dermal posttradiotherapy lesions, in grades 1 and 2.
Exclusion
- Patients with dermal lesions in grade greater than 2.
- Skin cancer invasion or distant tumor metastasis.
- Concurrent chemotherapy with RT, severe / extensive burns, moisture, erosion or suppuration in the skin, history of connective tissue disorders, severe mental disorder (dementia, drug addiction, etc.).
- History of hypersensitivity reaction to any of the ingredients of the studio cream.
- Participants involved in other clinical trials within that month.
Key Trial Info
Start Date :
July 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2023
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT04116151
Start Date
July 19 2022
End Date
July 30 2023
Last Update
February 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cordoba
Córdoba, Spain, 14011